A detailed history of Tealwood Asset Management Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Tealwood Asset Management Inc holds 37,120 shares of AZN stock, worth $2.43 Million. This represents 1.27% of its overall portfolio holdings.

Number of Shares
37,120
Previous 37,660 1.43%
Holding current value
$2.43 Million
Previous $2.94 Million 1.53%
% of portfolio
1.27%
Previous 1.77%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$76.67 - $87.62 $41,401 - $47,314
-540 Reduced 1.43%
37,120 $2.89 Million
Q2 2024

Jul 09, 2024

SELL
$66.81 - $80.83 $32,068 - $38,798
-480 Reduced 1.26%
37,660 $2.94 Million
Q1 2024

Apr 11, 2024

BUY
$61.03 - $69.57 $20,872 - $23,792
342 Added 0.9%
38,140 $2.58 Million
Q4 2023

Jan 08, 2024

SELL
$61.89 - $69.28 $37,381 - $41,845
-604 Reduced 1.57%
37,798 $2.55 Million
Q3 2023

Nov 08, 2023

SELL
$64.85 - $71.7 $26,783 - $29,612
-413 Reduced 1.06%
38,402 $2.6 Million
Q2 2023

Jul 26, 2023

SELL
$69.91 - $75.81 $53,760 - $58,297
-769 Reduced 1.94%
38,815 $2.78 Million
Q1 2023

Apr 12, 2023

SELL
$63.15 - $71.6 $69,086 - $78,330
-1,094 Reduced 2.69%
39,584 $2.75 Million
Q4 2022

Jan 17, 2023

SELL
$54.21 - $70.44 $122,080 - $158,630
-2,252 Reduced 5.25%
40,678 $2.76 Million
Q3 2022

Nov 16, 2022

BUY
$53.02 - $135.75 $9,013 - $23,077
170 Added 0.4%
42,930 $2.35 Million
Q2 2022

Jul 20, 2022

SELL
$59.26 - $71.14 $42,904 - $51,505
-724 Reduced 1.66%
42,760 $2.83 Million
Q1 2022

May 02, 2022

SELL
$55.72 - $67.12 $5,460 - $6,577
-98 Reduced 0.22%
43,484 $2.89 Million
Q4 2021

Mar 15, 2022

SELL
$54.02 - $63.83 $164,220 - $194,043
-3,040 Reduced 6.52%
43,582 $2.54 Million
Q3 2021

Dec 02, 2021

SELL
$55.56 - $60.79 $157,068 - $171,853
-2,827 Reduced 5.72%
46,622 $2.8 Million
Q1 2021

Jun 21, 2021

SELL
$47.16 - $54.44 $220,520 - $254,561
-4,676 Reduced 8.64%
49,449 $2.46 Million
Q4 2020

Mar 09, 2021

SELL
$48.52 - $58.02 $134,303 - $160,599
-2,768 Reduced 4.87%
54,125 $2.71 Million
Q3 2020

Dec 14, 2020

SELL
$53.07 - $61.1 $111,393 - $128,248
-2,099 Reduced 3.56%
56,893 $3.12 Million
Q2 2020

Aug 03, 2020

SELL
$43.1 - $55.31 $973,715 - $1.25 Million
-22,592 Reduced 27.69%
58,992 $3.12 Million
Q1 2020

May 13, 2020

SELL
$37.79 - $51.33 $213,286 - $289,706
-5,644 Reduced 6.47%
81,584 $3.64 Million
Q4 2019

Jan 16, 2020

BUY
$42.46 - $50.46 $8,109 - $9,637
191 Added 0.22%
87,228 $4.35 Million
Q3 2019

Oct 23, 2019

SELL
$40.12 - $45.47 $71,493 - $81,027
-1,782 Reduced 2.01%
87,037 $3.88 Million
Q2 2019

Aug 06, 2019

SELL
$37.28 - $41.68 $111,168 - $124,289
-2,982 Reduced 3.25%
88,819 $3.67 Million
Q1 2019

Apr 15, 2019

SELL
$35.49 - $43.02 $173,084 - $209,808
-4,877 Reduced 5.04%
91,801 $3.71 Million
Q4 2018

Jan 15, 2019

SELL
$36.86 - $41.49 $96,388 - $108,496
-2,615 Reduced 2.63%
96,678 $3.67 Million
Q3 2018

Oct 16, 2018

BUY
$34.76 - $39.72 $161,564 - $184,618
4,648 Added 4.91%
99,293 $3.93 Million
Q2 2018

Jul 25, 2018

BUY
$34.55 - $37.05 $3.27 Million - $3.51 Million
94,645 New
94,645 $3.32 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Tealwood Asset Management Inc Portfolio

Follow Tealwood Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tealwood Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tealwood Asset Management Inc with notifications on news.